Abstract
Trypanosoma cruzi is the protozoan that causes Chagas disease (CD), an endemic parasitosis in Latin America distributed around the globe. If CD is not treated in acute phase, the parasite remains silent for years in the host's tissues in a chronic form, which may progress to cardiac, digestive or neurological manifestations. Recently, studies indicated that the gastrointestinal tract represents an important reservoir for T. cruzi in the chronic phase. During interaction T. cruzi and host cells release extracellular vesicles (EVs) that modulates the immune system and infection, but the dynamics of secretion of host and parasite molecules through these EVs is not understood. Now, we used two cell lines: mouse myoblast cell line C2C12, and human intestinal epithelial cell line Caco-2to simulate the environments found by the parasite in the host. We isolated large EVs (LEVs) from the interaction of T. cruzi CL Brener and Dm28c/C2C12 and Caco-2 cells upon 2 and 24 h of infection. Our data showed that at two hours there is a strong cellular response mediated by EVs, both in the number, variety and enrichment/targeting of proteins found in LEVs for diverse functions. Qualitative and quantitative analysis showed that proteins exported in LEVs of C2C12 and Caco-2 have different patterns. We found a predominance of host proteins at early infection. The parasite-host cell interaction induces a switch in the functionality of proteins carried by LEVs and a heterogeneous response depending on the tissues analyzed. Protein–protein interaction analysis showed that cytoplasmic and mitochondrial homologues of the same parasite protein, tryparedoxin peroxidase, were differentially packaged in LEVs, also impacting the interacting molecule of this protein in the host. These data provide new evidence that the interaction with T. cruzi leads to a rapid tissue response through the release of LEVs, reflecting the enrichment of some proteins that could modulate the infection environment.
Similar content being viewed by others
Introduction
Trypanosoma cruzi is the protozoan that causes Chagas disease (CD)1, a parasitosis considered endemic in 21 countries in Latin America, with more than 6 million infected people2. T. cruzi has a very complex heteroxenous biological cycle, involving insect vectors of the Reduviidae family and mammalian hosts. Several aspects make the study of this pathogen more complex: the peculiar biology of the parasite and the transformations it undergoes, including multiple evolutionary stages; its adaptive capacity in different environments; the presence of distinct phenotypes between different strains and the pathophysiology of the disease, which involves an acute phase followed by persistence of the pathogen for many years in the host, that can develop a chronic phase of the disease.
Even after more than 100 years of its discovery, it is still not understood which factors determine the clinical evolution of CD. Host factors (such as the immune system) and parasite factors (such as differences between strains and infection routes) participate in the pathophysiology of the disease which generally involves myocardial and intestinal complications3. Recently, a series of works indicate that the gastrointestinal tract represents an important reservoir for T. cruzi in the chronic phase4,5,6,7,8. However, still little is known about the factors that influence the persistence and choice of the parasite by certain host tissues.
In this context, extracellular vesicles (EVs) may be acting as communicators between the parasite and host cells, facilitating invasion and modulating the immune system9,10,11,12,13,14,15,16. EVs are a diverse group of nanovesicles surrounded by a phospholipid bilayer constitutively released by either any prokaryotic or eukaryotic cell. The term EVs comprehends mainly two types of vesicles: exosomes, originated in multivesicular bodies of endocytic origin (ranging in diameter from 30 to 150 nm) and microvesicles (MVs), shed directly from the plasma membrane (100–1000 nm size). Due to the overlapping of physical characteristics (such as size) between MVs and exosomes and the difficulty of separating just one subpopulation with purity, the International Society of Extracellular Vesicles recommends the use of technical-operational terms, such as “Large Extracellular Vesicles” (LEVs, which correspond mainly to MVs) and “Small Extracellular Vesicles” (SEVs, mainly exosomes)17. Their packed and released cargos are very diverse and include lipids, proteins and different populations of nucleic acids and diverse biomolecules18. During contact between T. cruzi and host cells, there is an increase in the release of EVs, which constitute a mixture of parasite and host particles, including fusion between EVs19.
In this study, we used two cell lines to simulate the environments found by the parasite in the host: mouse myoblast cell line C2C12, and human intestinal epithelial cell line Caco-2-. We isolated large EVs (LEVs) derived from C2C12 and Caco-2 cells after 2 h and 24 h of infection. For this, T. cruzi culture-derived trypomastigotes (TCTs) belonging to two strains with distinct genetic and phenotypic characteristics (CL Brener, belonging to DTU Tc VI and Dm28c belonging to DTU Tc I)20,21,22. Figure 1 summarize the general strategy of the study. Number, variety and functionality of proteins identified in LEVs of C2C12 and Caco-2 indicate different patterns of proteins exported in LEVs during the infection. We found a predominance of host proteins at early infection. The interaction of the parasite with the host cell induces a switch in the functionality of proteins carried by LEVs which also differs between myoblasts and epithelial intestinal cells. Furthermore, protein–protein interaction analysis indicates that LEVs carry key proteins for host–pathogen interaction, which could participate in the pathogenesis of CD.
Methods
Cell culture
Cell lines Vero (epithelial—monkey), C2C12 (myoblast—mouse), Caco-2 (intestinal epithelium—human) were obtained from the London Metropolitan University cell bank gently offered by Dr. Jameel Inal (London Metropolitan University, UK) and maintained in RPMI medium supplemented with 10% fetal bovine serum (FBS), at 37 °C with 5% CO223. Tissue-derived trypomastigotes (TCT) from CL Brener (Tc VI) and Dm28c (Tc I) T. cruzi strains were obtained from the supernatant of Vero cells after 4–5 days of infection of the cells with TCTs (maintained with daily changes of RPMI 5% FBS medium)24.
Induction and purification of LEVs
LEVs were isolated from the supernatant of the interaction of C2C12 or Caco-2 cells with T. cruzi TCTs in a 5:1 ratio (parasites:cell) in RPMI medium in the absence of FBS. Cells were plated in 6-well plates (5 × 105 cells) 16–24 h before interaction. TCTs were washed in medium without FBS and added (2.5 × 106 TCTs) to interact with cells for 2 h (37 °C, 5% CO2) in the absence of FBS. After 2 h incubation, the supernatant was collected for LEV isolation (then called 2 h LEVs). After collection, the cells (control or that were in contact with the parasites) received medium (5% FBS) and were incubated for another 24 h. After 24 h, the medium was replaced by RPMI without FBS and the supernatant was collected 2 h after changing the medium (called 24 h LEVs). LEVs derived from isolated C2C12, Caco-2 and T. cruzi TCTs were used as controls. Samples were obtained in duplicates. The collected supernatants were subjected to differential centrifugation for the isolation of LEVs. First, the supernatant was centrifuged at 500×g for 5 min. The supernatant was transferred to a new tube and centrifuged at 4000×g for 30 min to remove cellular debris. Them, LEVs were obtained by 11,000×g/120 min centrifugation. The pellets containing the LEVs were resuspended in PBS. Protein concentrations in EVs were determined using the Pierce-BCA protein assay kit (Thermo Scientific, USA) as described by the manufacturer.
Protein preparation and analysis by mass spectrometry
Five micrograms of LEV proteins from duplicates of each condition were separated by 12% SDS-PAGE, stained with Coomassie Blue R-250, and submitted for in-gel protein digestion, as described elsewhere25 (Supplementary Fig. 1). Briefly, the whole gel lane for each sample was cut into approximately 1 mm3 cubes and destained (25 mM NH4HCO3 in 50% ethanol). Proteins were reduced (10 mM DTT in 100 mM NH4HCO3), alkylated (55 mM iodoacetamide in 100 mM NH4HCO3) and digested in gel with trypsin (sequencing grade modified, Promega) at a concentration of 12.5 ng/uL for 16 h at 37 °C. Peptides were extracted from the gel26 and desalted using C18-StageTips24 prior to analysis. Tryptic peptides were then separated by online reversed phase nanoscale capillary liquid chromatography (nanoLC) and analyzed by electrospray mass spectrometry in tandem (ESI–MS/MS) in a nanoLC-1D plus and autosampler as-2 (Eksigent) coupled to an LTQ Orbitrap XL ETD (Thermo Fisher Scientific). The peptide mixtures were separated in a packed emitter column with 15 cm length, 75 µm inner diameter, 3 µm C18 particles. Separation was carried out with a flow rate of 250 nL/min during 60 min using as mobile phases 0.1% acid formic, 5% DMSO in LC–MS water (phase A) and 0.1% formic acid, 5% DMSO in acetonitrile (phase B), with a linear gradient from 5 to 40% acetonitrile. Peptides were ionized by nanoelectrospray (2.7 kV) and injected into the mass spectrometer. Mass spectra were obtained by data-dependent acquisition in the orbitrap within a m/z window ranging from 300 to 1800, resolution of 60,000 at 400 m/z and AGC target of 106. The “lock mass” option was enabled at 401.922718 m/z to improve mass accuracy. The MS/MS was carried out in the linear ion trap, where the 10 most intense precursor ions from each full scan were isolated at an AGC target of 3 × 104 and fragmented by CID. The precursor ions were dynamically excluded for 90 s.
Data analysis
For protein identification and quantification, raw data from the LC–MS/MS runs was analyzed in the MaxQuant platform27, version 2.2.0.0, using a reversed decoy databases of T. cruzi CL Brener (19,242 sequences), T. cruzi Dm28c (15,319 sequences), Homo sapiens (81,791 sequences), and Mus musculus (55,260 sequences), downloaded on march 22, 2023, from TritrypDB28 and UniprotDB29. The search parameters were MS tolerance of 20 ppm (Orbitrap), MS/MS tolerance of 0.5 Da (Iontrap), minimum peptide length of seven amino acids and trypsin with specific cleavage, allowing for two missed cleavages. Carbamidomethylation of cysteines was set as a fixed modification and methionine oxidation and protein N-terminal acetylation as variable modifications. The match between runs algorithm was used. A false discovery rate (FDR) of 1% was applied to the PSM and protein levels. After the removal of potential contaminants, reverse and ‘only identified by site’ hits, proteins identified in the two replicates of each condition were considered on further analyses. The hierarchical clustering was performed using the Euclidean distance in Perseus software v. 2.0.930, the intensity (XIC values) of the proteins were transformed to log2 and the missing values were replaced by the normal distribution values of the data set (width: 0.3; down shift: 1.8). In quantitative analysis we use MaxQuant to calculate iBAQ value of proteins. The iBAQ value is obtained by dividing protein intensities by the number of theoretically observable tryptic peptides31. Proteins with iBAQ values calculated in at least 2 replicates per condition were Log2 transformed and considered in the t-test analysis with a permutation-based FDR calculation using FDR 0.05 and S0 0.1. The functional analysis of proteins found in LEVs was performed by gene ontology (G.O.) enrichment analysis (https://geneontology.org/)32. The subcellular localization analysis of LEV proteins was carried out using the website DeepLoc (https://services.healthtech.dtu.dk/services/DeepLoc-2.0)33 and cellular localizations with a presence greater than 3% in all EVs are presented in the graphs. The Venn diagrams were created using the BioVenn tool34. The protein–protein interactions were visualized using the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING)35 in Cytoscape stringApp 2.036 with high-confidence score cutoff of 0.90 and organic layout to group and locate the nodes.
Results
Protein patterns in LEVs released from myoblast and intestinal epithelium cells during T. cruzi infection highlight host dominance at early infection
Based on recent findings that the gastrointestinal tract represents an important reservoir for T. cruzi in the chronic phase and that the muscle tissues are particularly compromised during the pathogenesis of CD4,5,6,7,8, we hypothesized that the interaction of the parasite with the intestinal and muscular tissues, could result in different patterns of extracellular vesicle release. In order to investigate the hypothese, we used mass spectrometry-based proteomics to analyze the protein content of LEVs released in vitro by intestinal and muscular cell lines upon 2 h of interaction and 24 h of infection with T. cruzi TCTs (Fig. 1). The size distribution of LEVs in each sample shown that the method was able to mostly isolate LEVs and identify their proteins (Supplementary Fig. 2A,B, respectively).
We identified a greater variety of proteins in LEVs released after the first two hours of interaction with the parasite, compared to those from 24 h post infection (h.p.i.), except for intestinal epithelium (Caco-2) interacting with T. cruzi Dm28c (Fig. 2A). When looking into proteins of host and parasite origin, it is possible to notice that contact with the parasite for 2 h induces a greater secretion of host proteins in LEVs, which equals after 24 h of infection (Fig. 2B). In addition, a higher proportion of host proteins were identified in LEVs derived from the interaction of the parasite with Caco-2 (82.5% and 75.7% for CL Brener and Dm28c, respectively), when compared to myoblasts (C2C12) (70.7% and 58.8%, for CL Brener and Dm28c, respectively) cells. Detailed results are available in Supplementary Table 1.
To understand whether the profile of host proteins present in LEVs released in the different contexts studied would also differ, we analyzed the subcellular localization of the protein sets found in each sample (Supplementary Table 2). Cytoplasmic proteins are the majority (> 40%) and membrane and endoplasmic reticulum proteins had a lower proportion in all LEVs analyzed (less than 8%), both at 2 h.p.i. (Fig. 2C) and 24 h.p.i. (Fig. 2D). Despite the general cytoplasmic majority, a predominance of different sublocations in different samples was observed. For example, in LEVs derived from C2C12 after the first 2 h.p.i. (with or without contact with parasites), an expressive number (> 10%) of nuclear proteins is seen. On the other hand, extracellular proteins appeared in greater proportion (> 20%) in Caco-2 LEVs, mainly after 24 h.p.i. At the moment, we do not know if these proteins could have been “pelleted” together with the EVs (as contaminants) or if they represent a phenomenon of extracellular protein export in the EVs, the biological value of this data still needs to be explored and validated. Also, mitochondrial proteins appeared only in EVs derived from the first two hours of infection in all LEVs.
Qualitative and quantitative analysis of proteins identified in LEVs indicate a different export profile in host cells under interaction with the T. cruzi
The qualitative analysis of the proteins identified in the LEVs showed that, among the control LEVs (cells without contact with parasites for 2 and 24 h), four proteins are common to all (annexin A2, fructose biphosphate aldolase, plakoglobin and tubulin alpha 1-B) (Supplementary Fig. 3), two of which (annexin and tubulin) are commonly found in EVs37. On the other hand, the overlap of identified proteins is greater between the control samples of each cell line (32 common proteins in Caco-2 and 18 in C2C12), demonstrating the heterogeneous profile of LEV proteins from different cell lines. Despite the high number of proteins shared between 2 h LEVs in control and infected cells (27.9% for C2C12 and 48.3% for Caco-2), we identified 23 (26.7%) and 13 (14.9%) proteins found exclusively in interaction of both strains with myoblasts and epithelial cells, respectively (Fig. 3A,B and Table 1). Among them, we found proteins involved in metabolism, cytoskeleton, immunoglobulins, and cellular transport. In 24 h LEVs, we identified a smaller number of proteins exclusive from the interaction (heat shock protein HSP 90-beta for myoblast and plakophilin-1 and histone H4 for epithelial cells (Fig. 3C,D).
The expression profile analysis of the proteins allowed the identification of different clusters in the analyzed conditions (Figs. 4 and 5). For T. cruzi proteins (Fig. 4), it is possible to see that tubulin (alpha tubulin chain and beta tubulin) was consistently identified. Furthermore, a conserved hypothetical protein (TriTrypDB ID: C4B63_40g107), annotated as basal body protein and orthologous protein in other T. cruzi strains, was also found in all EVs. Proteins such as tryparedoxin peroxidase, elongation factor 1-alpha and 2, histones H4, H2A and H2B, calreticulin and heat shock protein 70 and 85 increased in LEVs of myoblasts (C2C12) with T. cruzi in the first 2 h of infection, but decreased after 24 h (Fig. 4A). For epithelial cells (Caco-2), heat shock protein 70 and 85 appear with a constant profile in all samples (Fig. 4B).
Regarding host cell proteins identified in the LEVs (Fig. 5), it is possible to notice that proteins such as actin, annexin A2, elongation factor 1-alpha and fibronectin remain abundant in all LEVs coming from myoblasts (C2C12) (with or without contact with T. cruzi) (Fig. 5A). It is also possible to note that certain proteins are abundant in 2 h LEVs and have a low detection in LEVs coming from cells 24 h.p.i. In epithelial (Caco-2) (Fig. 5B), a high concentration of proteins such as suprabasin, keratinocyte protein rich in proline, dermcidin, desmoplakin, plakoglobin, desmocollin, desmoglein, polyubiquitin-C and elongation factor 1-alpha was seen in all samples. Interestingly, some of these proteins are important in cell adhesion processes.
In order to identify differentially abundant proteins between conditions involving the parasite and host cells, we compared the iBAQ values of proteins between T. cruzi and different host cells for in 2 h and 24 h h conditions (Supplementary Table 6). The analysis reveals 13 differentially abundant proteins in parasite interaction with C2C12 and Caco-2 during 2 h (Fig. 6A), and 6 proteins in 24 h post infection (Fig. 6B). Differentially abundant proteins related to adhesion and immune response were identified in the vesicles of host cells while from parasite were identified proteins related to carbohydrate and amino acid metabolism, and this response was more intense in the 2 h.p.i. and Caco-2 cell (Table 2).
All together, our analysis of LEV proteins indicate that 24 h after interaction with T. cruzi, there is a lower cellular response through the release of EVs.
The parasite-host interaction induces a switch in the functionality of proteins carried by LEVs in early infection
In order to understand the functions of the host proteins carried by their LEVs, we analyzed the biological processes enriched in which these proteins would be involved. All enriched categories (p-value < 0.05) are shown in Supplementary Table 3 and some main processes are shown in Fig. 7. Interestingly, LEVs 2 h from control cells (which had no contact with T. cruzi) were enriched for one GO term only: cellular response to chemical stimulation for myoblasts (C2C12) (Fig. 7A) and autocrine signaling for epithelial cells (Caco-2) (Fig. 7B). On the other hand, when cells interact with T. cruzi, more GO terms appear enriched, showing that the composition of EVs is affected by exposure to the pathogen. Biological processes of cell response, such as response to cytokines/interleukins, protein folding, peptide antigen assembly with MHC I, neutrophil aggregation, regulation of cell death, and biological processes involved in inter-species interaction and cell adhesion appear over-represented in 2 h LEVs from cells in contact with T. cruzi.
LEVs carry key proteins for parasite-host interaction
Taking into consideration that EVs carry parasitic molecules, we screened in silico for potential protein–protein interactions (PPI) between pathogen LEV proteins and host cells. We identified 438 potential interactions between T. cruzi (CL Brener 178; Dm28c 260) and epithelial cells (Fig. 8), and 689 interactions between T. cruzi (CL Brener 312; Dm28c 377) and myoblast cells (Fig. 9) (Supplementary Table 4). These interactions are carried out by 10 proteins from the CL Brener strain (Fig. 8A) and 9 from the Dm28c strain (Fig. 8B), interacting with 92 and 131 proteins from the epithelial cells, respectively. In the parasite interaction with myoblast cells, 19 proteins from the CL Brener strain (Fig. 9A) and 17 from the Dm28c strain (Fig. 9B) were mapped, interacting with 152 and 168 proteins, respectively.
An important virulence factor mapped by PPI analysis was tryparedoxin peroxidase (TP), which is an important component in the antioxidant system of T. cruzi during host infection38. T. cruzi has a cytosolic TP and a mitochondrial TP39. Both TPs were identified, but in different parasite-host cell conditions. For example, in the CL Brener-epithelial cells interaction only cytosolic TP (Q4CVR5) was identified, while in the interaction of this same strain with myoblast, cytosolic and mitochondrial TP (Q4CX87) were identified. In the Dm28c-epithelial cells interaction, neither of the two TPs was identified, whereas in the interaction of this strain with myoblasts, the mitochondrial TP was identified.
Different interaction partners were mapped according to the type of host cell. For example, in the interaction with epithelial cells (Caco-2), the cytosolic TP (Q4CVR5) interacts with Lysosomal-associated membrane protein and with cell growth-inhibiting gene 2 protein (Fig. 8). In the interaction with myoblast (C2C12), the mitochondrial TP (Q4CX87) interacts with the CD63 and CD9 antigens (Fig. 9) opening the idea that the dynamic of interaction between pathogens and host cells could be varied and different trough LEVs in each tissue.
Discussion
Chagas disease represents a spectrum of pathogenesis, varying both in its severity and in the organs affected. The fine balance between various host factors (such as the immune response) and parasitic factors determines the outcome of the infection and its pathogenesis. The present study was carried out to evaluate the extent to which the release of extracellular vesicles could help to elucidate the interaction of T. cruzi with different tissues. Our proteomics results showed that LEVs coming from myoblast (C2C12) and epithelial cells (Caco-2) cells have different components, and that the infection influences the composition of the LEVs. We have seen a difference in the ratio of host and parasite proteins between two T. cruzi strains at 2 h and 24 h after infection. Our data showed that during the first two hours of contact with T. cruzi, there is a strong cellular response mediated by EVs, both in the number of proteins found in LEVs and in the enrichment/targeting of proteins for diverse functions. The work of Ramirez et al.19 shows that the interaction of T. cruzi metacyclics and TCTs with THP-1 macrophages (for 1 h) contribute proteins to the formation of EVs, with 25% (metacyclics) and 12% (TCTs) of the proteins found in the EVs under these conditions belonging to T. cruzi, while only 5% of the proteins are parasitic in the interaction with epimastigotes. In our results, the percentage of parasitic proteins found in LEVs varies from approximately 20–40%, a number that may be higher due to the longer interaction time (2 h). Our data show 30–50 proteins found in control EVs (C2C12 and Caco-2), which is similar to that reported by Ramirez et al. 2017 (54 THP-1 proteins in the absence of parasites). In the same way as in our results, Ramirez et al. 2017 reported that the number of total proteins increases upon interaction with T. cruzi (from 54 proteins in the control to 91 and 110 when interacting with metacyclics and TCTs, respectively). Interestingly, the authors show that parasite and host EVs fuse19, which could hypothetically result in better uptake of these particles in certain tissues, depending on the components they carry.
Bautista-López et al.40 characterized EVs secreted from Vero cells infected with T. cruzi and showed that only 10% of the total proteins were of parasitic origin. The group of T. cruzi proteins most abundant in EVs were from the trans-sialidases family, which was also found in another study that evaluated EVs from isolated parasites11, however, these proteins were not very representative in our data. We identified three trans-sialidases (groups I, II and V) in the T. cruzi-myoblast interaction and only one (group I) in the T. cruzi-epithelial cells interaction. This difference is probably because these previous studies evaluated EVs coming from cells on the 4th day after infection (where the parasites have already replicated and differentiated into trypomastigotes, which express high levels of trans-sialidases)41, while our data were obtained within 24 h after infection, when the parasites are just beginning to replicate as amastigotes.
Cronenberger-Andrade et al.15 evaluates the secretion of EVs from macrophages (THP-1) infected by T. cruzi. A total of 123 proteins were found in EVs from uninfected THP1 and 89 were found in EVs from infected cells, out of a total of 154 proteins in both samples. Interestingly, T. cruzi proteins found in infected THP-1 EVs such as HSP60, tryparedoxin peroxidase, trans-sialidase Group II, flagellar calcium-binding protein were also found in our experiment (Table S1). Most of the proteins found in EVs are involved in binding, immunological and metabolic processes.
Parasite and host proteins identified in the present study were compared with proteins found in the works of Ramirez et al.19, Bautista-López et al.40 and Cronenberger-Andrade et al.15. Fifteen proteins were identified in common with those published by Ramirez et al. (2017) in 2 h LEVs and 7 proteins in 24 h LEVs (Supplementary Table 5). Among the functions observed in these proteins are binding, catalytic activity, structural molecule activity, and translation regulatory activity.
Although our results show that LEVs carry important parasitic and cellular components, it remains an open question whether they have the capacity to influence the parasite’s tropism for certain host tissues. A limitation of experimental work with T. cruzi is not being able to simulate the complex environment of chronic infection in vitro. Trying to simulate possible environments found by parasites, we used cell lines that would represent muscle and intestinal tissues to study their EVs. It was possible to evidence a considerable difference between LEVs derived from the myoblasts and epithelial cells lines. However, it is important to highlight that a pattern of strong cellular response to infection was seen and that LEVs released from these cells could carry information to adjacent tissues as a warning signal. An enrichment of adhesion-related proteins was noted in LEVs derived from epithelial cells (Caco-2) in contact with the parasite.
Our data also show the ability of LEVs to carry virulence factor from parasites. For example, one of the proteins detected in LEVs was cruzipain, a highly mannosylated cysteine protease that has been described as cleaving kininogen in host cells, creating short-lived kinins which bind to the bradykinin receptor to stimulate IP3-mediated Ca2 + release, with such a pathway being associated with parasite internalization42. Another important factor found in LEVs is calreticulin, a molecule that inhibits both the classical and lectin complement pathways, protecting the parasite from lysis43. These data open the way for new studies that investigate the role of EVs in modulating host responses during CD.
Data availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE44. Partner repository with the dataset identifier PXD046906.
References
Chagas, C. Nova tripanozomiaze humana: Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Mem. Inst. Oswaldo Cruz https://doi.org/10.1590/S0074-02761909000200008 (1909).
PAHO (Pan-American Health Organization). Factsheet: Chagas Disease in the Americas for Public Health Workers. Accessed in May 2023.
Alves, M. J. & Mortara, R. A. A century of research: What have we learned about the interaction of Trypanosoma cruzi with host cells?. Mem. Inst. Oswaldo Cruz 104(Suppl 1), 76–88. https://doi.org/10.1590/s0074-02762009000900013 (2009).
Lewis, M. D., Francisco, A. F., Taylor, M. C., Jayawardhana, S. & Kelly, J. M. Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathy. Cell. Microbiol. 18(10), 1429–1443. https://doi.org/10.1111/cmi.12584 (2016).
Ward, A. I. et al. In vivo analysis of Trypanosoma cruzi persistence foci at single-cell resolution. mBio 11(4), e01242-e1320. https://doi.org/10.1128/mBio.01242-20 (2020).
Taylor, M. C. et al. Intracellular DNA replication and differentiation of Trypanosoma cruzi is asynchronous within individual host cells in vivo at all stages of infection. PLoS Negl. Trop. Dis. 14(3), e0008007. https://doi.org/10.1371/journal.pntd.0008007 (2020).
Khan, A. A. et al. Local association of Trypanosoma cruzi chronic infection foci and enteric neuropathic lesions at the tissue micro-domain scale. PLoS Pathog. 17(8), e1009864. https://doi.org/10.1371/journal.ppat.1009864 (2021).
Ward, A. I., Lewis, M. D., Taylor, M. C. & Kelly, J. M. Incomplete recruitment of protective T cells is associated with Trypanosoma cruzi persistence in the mouse colon. Infect. Immun. 90(2), e0038221. https://doi.org/10.1128/IAI.00382-21 (2022).
Cestari, I., Ansa-Addo, E., Deolindo, P., Inal, J. M. & Ramirez, M. I. Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles. J. Immunol. (Baltim. Md. 1950) 188(4), 1942–1952. https://doi.org/10.4049/jimmunol.1102053 (2012).
Wyllie, M. P. & Ramirez, M. I. Microvesicles released during the interaction between Trypanosoma cruzi TcI and TcII strains and host blood cells inhibit complement system and increase the infectivity of metacyclic forms of host cells in a strain-independent process. Pathogens Dis. 75(7), ftx077. https://doi.org/10.1093/femspd/ftx077 (2017).
Ribeiro, K. S. et al. Proteomic analysis reveals different composition of extracellular vesicles released by two Trypanosoma cruzi strains associated with their distinct interaction with host cells. J. Extracell. Vesicles https://doi.org/10.1080/20013078.2018.1463779 (2018).
Retana Moreira, L., Rodríguez Serrano, F. & Osuna, A. Extracellular vesicles of Trypanosoma cruzi tissue-culture cell-derived trypomastigotes: Induction of physiological changes in non-parasitized culture cells. PLoS Negl. Trop. Dis. 13(2), e0007163. https://doi.org/10.1371/journal.pntd.0007163 (2019).
Torrecilhas, A. C. T. et al. Trypanosoma cruzi: Parasite shed vesicles increase heart parasitism and generate an intense inflammatory response. Microbes Infect. 11(1), 29–39 (2009).
Nogueira, P. M. et al. Vesicles from different Trypanosoma cruzi strains trigger differential innate and chronic immune responses. J. Extracell. Vesicles https://doi.org/10.3402/jev.v4.28734 (2015).
Cronemberger-Andrade, A. et al. Trypanosoma cruzi-infected human macrophages shed proinflammatory extracellular vesicles that enhance host-cell invasion via toll-like receptor 2. Front. Cell. Infect. Microbiol. 10, 99. https://doi.org/10.3389/fcimb.2020.00099 (2020).
Chowdhury, I. H. et al. Gene expression profiling and functional characterization of macrophages in response to circulatory microparticles produced during Trypanosoma cruzi infection and chagas disease. J. Innate Immun. 9(2), 203–216. https://doi.org/10.1159/000451055 (2017).
Théry, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7(1), 1535750. https://doi.org/10.1080/20013078.2018.1535750 (2018).
van Niel, G. et al. Challenges and directions in studying cell–cell communication by extracellular vesicles. Nat. Rev. Mol. Cell Biol. 23(5), 369–382 (2022).
Ramirez, M. I. et al. Dynamic flux of microvesicles modulate parasite–host cell interaction of Trypanosoma cruzi in eukaryotic cells. Cell. Microbiol. 19(4), e12672 (2017).
de Melo Medeiros, M., Araújo-Jorge, T. C., Batista, W. S., da Silva, T. M. O. A. & de Souza, A. P. Trypanosoma cruzi infection: Do distinct populations cause intestinal motility alteration?. Parasitol. Res. 107, 239–242 (2010).
Resende, B. C. et al. The influence of recombinational processes to induce dormancy in Trypanosoma cruzi. Front. Cell. Infect. Microbiol. 10, 5 (2020).
Sturm, N. R., Vargas, N. S., Westenberger, S. J., Zingales, B. & Campbell, D. A. Evidence for multiple hybrid groups in Trypanosoma cruzi. Int. J. Parasitol. 33(3), 269–279 (2003).
Ammerman, N. C., Beier-Sexton, M. & Azad, A. F. Growth and maintenance of Vero cell lines. Curr. Protocols Microbiol. https://doi.org/10.1002/9780471729259.mca04es11 (2008).
MacLean, L. M. et al. Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas’ disease drug discovery. PLoS Negl. Trop. Dis. 12(7), e0006612. https://doi.org/10.1371/journal.pntd.0006612 (2018).
Shevchenko, A., Tomas, H., Havlis, J., Olsen, J. V. & Mann, M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 1(6), 2856–2860. https://doi.org/10.1038/nprot.2006.468 (2006).
Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2(8), 1896–1906. https://doi.org/10.1038/nprot.2007.261 (2007).
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26(12), 1367–1372. https://doi.org/10.1038/nbt.1511 (2008).
Amos, B. et al. VEuPathDB: The eukaryotic pathogen, vector and host bioinformatics resource center. Nucleic Acids Res. 50(D1), D898–D911. https://doi.org/10.1093/nar/gkab929 (2022).
The UniProt Consortium. UniProt: The universal protein knowledgebase in 2023 (2023). Nucleic Acids Res. 51(D1), D523–D531. https://doi.org/10.1093/nar/gkac1052 (2023).
Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13(9), 731–740. https://doi.org/10.1038/nmeth.3901 (2016).
Schwanhäusser, B. et al. Global quantification of mammalian gene expression control. Nature 473, 337–342. https://doi.org/10.1038/nature10098 (2011).
Aleksander, S. A. et al. The Gene ontology knowledgebase in 2023. Genetics 224(1), iyad031. https://doi.org/10.1093/genetics/iyad031 (2023).
Thumuluri, V., Almagro Armenteros, J. J., Johansen, A. R., Nielsen, H. & Winther, O. DeepLoc 2.0: Multi-label subcellular localization prediction using protein language models. Nucleic Acids Res. 50(W1), W228–W234. https://doi.org/10.1093/nar/gkac278 (2022).
Hulsen, T., de Vlieg, J. & Alkema, W. BioVenn—a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genom. 9, 488. https://doi.org/10.1186/1471-2164-9-488 (2008).
Szklarczyk, D. et al. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47(D1), D607–D613. https://doi.org/10.1093/nar/gky1131 (2019).
Doncheva, N. T. et al. Cytoscape stringApp 20: Analysis and visualization of heterogeneous biological networks. J. Proteome Res. 22(2), 637–646. https://doi.org/10.1021/acs.jproteome.2c00651 (2023).
Mallia, A. et al. Proteomics of extracellular vesicles: Update on their composition, biological roles and potential use as diagnostic tools in atherosclerotic cardiovascular diseases. Diagnostics (Basel Switz.) 10(10), 843. https://doi.org/10.3390/diagnostics10100843 (2020).
López, L. et al. The cytosolic tryparedoxin peroxidase from Trypanosoma cruzi induces a pro-inflammatory Th1 immune response in a peroxidatic cysteine-dependent manner. Immunology 163(1), 46–59. https://doi.org/10.1111/imm.13302 (2021).
Wilkinson, S. R., Temperton, N. J., Mondragon, A. & Kelly, J. M. Distinct mitochondrial and cytosolic enzymes mediate trypanothione-dependent peroxide metabolism in Trypanosoma cruzi. J. Biol. Chem. 275(11), 8220–8225. https://doi.org/10.1074/jbc.275.11.8220 (2000).
Bautista-López, N. L. et al. Characterization and diagnostic application of Trypanosoma cruzi trypomastigote excreted-secreted antigens shed in extracellular vesicles released from infected mammalian cells. J. Clin. Microbiol. 55(3), 744–758. https://doi.org/10.1128/JCM.01649-16 (2017).
Colli, W. Trans-sialidase: A unique enzyme activity discovered in the protozoan Trypanosoma cruzi. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 7(13), 1257–1264. https://doi.org/10.1096/fasebj.7.13.8405811 (1993).
Duschak, V. G. & Couto, A. S. Cruzipain, the major cysteine protease of Trypanosoma cruzi: A sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review. Curr. Med. Chem. 16(24), 3174–3202. https://doi.org/10.2174/092986709788802971 (2009).
Ramírez, G. et al. Roles of Trypanosoma cruzi calreticulin in parasite-host interactions and in tumor growth. Mol. Immunol. 52(3–4), 133–140. https://doi.org/10.1016/j.molimm.2012.05.006 (2012).
Perez-Riverol, Y. et al. The PRIDE database resources in 2022: A hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50(D1), D543–D552. https://doi.org/10.1093/nar/gkab1038 (2022).
Acknowledgements
This study has received support from FIOCRUZ, CNPq and CAPES. MIR is currently a fellow from CNPq-Brazil. IVR is currently a fellow from CAPES/BRAZIL Post-doctorate Program.
Author information
Authors and Affiliations
Contributions
I.R. designed experiment, performed experiments, analysed results, prepared figures, wrote the main manuscript. B.S. performed experiments, prepared figures. RA analysed results, prepared figures, wrote the main manuscript. LF analysed results, wrote the main manuscript. MR obteined funding, designed experiments, analysed results, wrote the main manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rossi, I.V., de Almeida, R.F., Sabatke, B. et al. Trypanosoma cruzi interaction with host tissues modulate the composition of large extracellular vesicles. Sci Rep 14, 5000 (2024). https://doi.org/10.1038/s41598-024-55302-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-55302-3
Keywords
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.